LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System.

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 557 participants.

Also called NCT04790344

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 557 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04790344
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04790344. Allocation not applicable; no masking; primary purpose diagnostic. Start 2021-03-20 (actual); primary completion 2026-07-27 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System.
Condition
Heart Failure
Intervention (Device)
Investigational LUX-Dx ICM Implant
Lead sponsor
Boston Scientific Corporation (class: industry)

Record details

Record id
cardio:ct-nct04790344
Content hash
cef36db8cddc09d2916e81388e705196ced2fdf66c7192edf3940261aa9a89e8